Key Record Dates
ClinicalTrials.gov Identifier: | NCT05348577 |
---|---|
Brief Title: | Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC) (CAPItello280) |
First Submitted : | March 18, 2022 |
First Submitted that Met QC Criteria : | April 21, 2022 |
First Posted : | April 27, 2022 |
Last Update Submitted that Met QC Criteria : | March 14, 2024 |
Last Update Posted : | March 15, 2024 |